Meet the 2023 Laureates: Myles Brown, MD, and Márta Korbonits, MD, PhD, DSc, FRCP

Gerald D. Aurbach Award for Outstanding Translational Research

This annual award recognizes outstanding contributions to research that accelerates the transition of scientific discoveries into clinical applications. This year, the award has two worthy recipients, Myles Brown, MD; and Márta Korbonits, MD, PhD, DSc, FRCP.

Myles Brown, MD
Myles Brown, MD Director, Center for Cancer Epigenetics. Photo by Sam Ogden.

Brown is the Emil Frei III Professor of Medicine at Dana-Farber Cancer Institute and Harvard Medical School in Boston, Mass. He is an expert in oncology and a talented physician-scientist whose contributions have fundamentally reformulated the mechanistic understanding of hormone dependence of breast and prostate cancers, which has enabled the development of new therapies for these diseases.

Honored with several awards, including the Endocrine Society’s 2010 Edwin B. Astwood Award, Brown also was elected to the National Academy of Sciences in 2016, the American Academy of Arts and Sciences in 2017, and the National Academy of Medicine in 2020. He has been a member of the Endocrine Society since 2002 and served on the Editorial Board for the Endocrine Society’s journal, Molecular Endocrinology, which was incorporated into the journal Endocrinology in 2017.   

How has the Endocrine Society supported your professional development/career journey?

The Endocrine Society has had a major impact on my career. The annual meeting has been a wonderful place to connect with colleagues, many of whom have become lifelong friends.

As a Laureate Award recipient, do you have any advice for those just beginning their careers?

My advice to those beginning careers in research is to pick an important problem that they feel passionate about and to stick with it. Be self-critical, but to trust your own data and not be dissuaded by reviewers of papers and grants.

Márta Korbonits, MD, PhD, DSc, FRCP

Korbonits is the professor of endocrinology and metabolism at Queen Mary University of London. She is one of the top clinician scientists on the clinical, translational, and experimental aspects of pituitary tumorigenesis and familial isolated pituitary adenomas and has pioneered work on the metabolic effects of various hormones.

Her strength is the ability to set up basic science experiments based on key clinical questions and then translate these back to clinical studies. In addition, she looks after patients with endocrine diseases at St. Bartholomew’s Hospital, undertakes wide-ranging teaching activities and supervises MSc and PhD students. She currently serves on the Endocrine Society’s Annual Meeting Steering Committee and as president-elect of the Society for Endocrinology. She also received the Endocrine Society’s 2015 Delbert A. Fisher Research Scholar Award.

How has the Endocrine Society supported your professional development/career journey?

My yearly visits to the Endocrine Society meetings meant that I learned new ideas, formed new hypothesis, developed collaborations, and presented data in front of an informed and challenging audience.

As a Laureate Award recipient, do you have any advice for those just beginning their careers?

Trust your ideas!

ABOUT THE AWARD

The Gerald D. Aurbach Award for Outstanding Translational Research is presented in recognition of outstanding research that accelerates the transition of scientific discoveries into clinical applications. Translational research supported with this award will typically involve expertise, collaboration, and engagement across disciplines. Supported by the Gerald D. Aurbach Memorial Fund.

You may also like

  • Holly A. Ingraham, PhD, Receives FASEB Excellence in Science Lifetime Achievement Award

    Endocrine Society member Holly A. Ingraham, PhD, is the recipient of the FASEB Excellence in Science Lifetime Achievement Award. On April 8, the organization announced the winners of its 2024 Excellence in Science Awards, which highlight outstanding achievements by women in biological sciences who demonstrate not only excellence and innovation in their research fields, but…

  • Endocrine Society Celebrates Special Diabetes Program Extension

    The Endocrine Society applauds Congress for approving the first funding increase for the Special Diabetes Program in two decades. The U.S. Senate voted Friday March 8 to extend the program, which supports both diabetes care and research into type 1 diabetes, until the end of 2024. This is part of the six-bill package funding several…